Year |
Citation |
Score |
2016 |
Hsu D, Taylor P, Fletcher D, van Heeckeren R, Eastman J, van Heeckeren A, Davis P, Chmiel JF, Pearlman E, Bonfield T. CF Lung Infection and Inflammation: IL-17 Pathophysiology and Therapeutic Intervention. Infection and Immunity. PMID 27271746 DOI: 10.1128/Iai.00284-16 |
0.365 |
|
2016 |
Spoonhower KA, Davis PB. Epidemiology of Cystic Fibrosis. Clinics in Chest Medicine. 37: 1-8. PMID 26857763 DOI: 10.1016/J.Ccm.2015.10.002 |
0.315 |
|
2015 |
Davis PB. Another Beginning for Cystic Fibrosis Therapy. The New England Journal of Medicine. 373: 274-6. PMID 25981385 DOI: 10.1056/Nejme1504059 |
0.333 |
|
2015 |
Davis PB, Rio SD, Muntz JA, Dieckman L. Sweat chloride concentration in adults with pulmonary diseases. The American Review of Respiratory Disease. 128: 34-37. PMID 6870067 DOI: 10.1164/Arrd.1983.128.1.34 |
0.325 |
|
2015 |
Davis PB. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis The American Review of Respiratory Disease. 129: 911-914. PMID 6329048 DOI: 10.1164/Arrd.1984.129.6.911 |
0.365 |
|
2012 |
Drumm ML, Ziady AG, Davis PB. Genetic variation and clinical heterogeneity in cystic fibrosis. Annual Review of Pathology. 7: 267-82. PMID 22017581 DOI: 10.1146/Annurev-Pathol-011811-120900 |
0.301 |
|
2011 |
Davis PB. Therapy for cystic fibrosis--the end of the beginning? The New England Journal of Medicine. 365: 1734-5. PMID 22047565 DOI: 10.1056/Nejme1110323 |
0.3 |
|
2011 |
Ziady AG, Davis PB. Methods for evaluating inflammation in cystic fibrosis. Methods in Molecular Biology (Clifton, N.J.). 742: 51-76. PMID 21547726 DOI: 10.1007/978-1-61779-120-8_4 |
0.4 |
|
2011 |
Chen X, Shank S, Davis PB, Ziady AG. Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 93-102. PMID 20959809 DOI: 10.1038/Mt.2010.214 |
0.328 |
|
2009 |
Nichols DP, Ziady AG, Shank SL, Eastman JF, Davis PB. The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. American Journal of Physiology. Lung Cellular and Molecular Physiology. 297: L828-36. PMID 19700644 DOI: 10.1152/Ajplung.00171.2009 |
0.382 |
|
2008 |
Miller TJ, Davis PB. S163 is critical for FXYD5 modulation of wound healing in airway epithelial cells. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 16: 791-9. PMID 19128250 DOI: 10.1111/J.1524-475X.2008.00432.X |
0.317 |
|
2008 |
Perez A, van Heeckeren AM, Nichols D, Gupta S, Eastman JF, Davis PB. Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium. American Journal of Physiology. Lung Cellular and Molecular Physiology. 295: L303-13. PMID 18556801 DOI: 10.1152/Ajplung.90276.2008 |
0.417 |
|
2008 |
Miller TJ, Davis PB. FXYD5 modulates Na+ absorption and is increased in cystic fibrosis airway epithelia. American Journal of Physiology. Lung Cellular and Molecular Physiology. 294: L654-64. PMID 18263667 DOI: 10.1152/Ajplung.00430.2007 |
0.345 |
|
2007 |
Konstan MW, Schluchter MD, Xue W, Davis PB. Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 176: 1084-9. PMID 17872492 DOI: 10.1164/Rccm.200702-181Oc |
0.312 |
|
2007 |
Davis PB. Pacing the marathon: rate of decline of pulmonary function in cystic fibrosis. The Journal of Pediatrics. 151: 111-3. PMID 17643757 DOI: 10.1016/J.Jpeds.2007.03.060 |
0.333 |
|
2007 |
Strausbaugh SD, Davis PB. Cystic fibrosis: a review of epidemiology and pathobiology. Clinics in Chest Medicine. 28: 279-88. PMID 17467547 DOI: 10.1016/J.Ccm.2007.02.011 |
0.322 |
|
2007 |
Davis PB, Cooper MJ. Vectors for airway gene delivery. The Aaps Journal. 9: E11-7. PMID 17408235 DOI: 10.1208/Aapsj0901002 |
0.31 |
|
2007 |
Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, Davis PB. CFTR inhibition mimics the cystic fibrosis inflammatory profile. American Journal of Physiology. Lung Cellular and Molecular Physiology. 292: L383-95. PMID 16920886 DOI: 10.1152/Ajplung.00403.2005 |
0.4 |
|
2006 |
Ziady AG, Davis PB. Current prospects for gene therapy of cystic fibrosis. Current Opinion in Pharmacology. 6: 515-21. PMID 16890018 DOI: 10.1016/J.Coph.2006.04.008 |
0.341 |
|
2006 |
van Heeckeren AM, Schluchter MD, Xue W, Davis PB. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. American Journal of Respiratory and Critical Care Medicine. 173: 288-96. PMID 16272448 DOI: 10.1164/Rccm.200506-917Oc |
0.382 |
|
2006 |
Davis PB. Cystic fibrosis since 1938. American Journal of Respiratory and Critical Care Medicine. 173: 475-82. PMID 16126935 DOI: 10.1164/Rccm.200505-840Oe |
0.39 |
|
2006 |
Chen X, Davis PB. 397. Compacted DNA Nanoparticles Transfect Cells by Binding to Cell Surface Nucleolin Molecular Therapy. 13: S152. DOI: 10.1016/J.Ymthe.2006.08.459 |
0.308 |
|
2005 |
Kube DM, Fletcher D, Davis PB. Relation of exaggerated cytokine responses of CF airway epithelial cells to PAO1 adherence. Respiratory Research. 6: 69. PMID 16008840 DOI: 10.1186/1465-9921-6-69 |
0.394 |
|
2005 |
Kotlarchyk M, Lee Z, Cooper M, Davis PB, Ziady AG. 1104. Imaging of sec-R Directed and PEG-Stabilized Gene Transfer Nanoparticles in CF Mice Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.652 |
0.33 |
|
2005 |
Rhee M, Davis PB. 201. C105Y, a Novel Cell Penetrating Peptide Enhances Gene Transfer of Sec-R Targeted Molecular Conjugates Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.204 |
0.323 |
|
2004 |
Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ, Kowalczyk TH, Hyatt SL, Fink TL, Gedeon CR, Oette SM, Payne JM, Muhammad O, Ziady AG, Moen RC, et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Human Gene Therapy. 15: 1255-69. PMID 15684701 DOI: 10.1089/Hum.2004.15.1255 |
0.355 |
|
2004 |
Davis PB, Drumm ML. Some like it hot: curcumin and CFTR. Trends in Molecular Medicine. 10: 473-5. PMID 15464445 DOI: 10.1016/J.Molmed.2004.08.001 |
0.372 |
|
2004 |
Davis PB, Schluchter MD, Konstan MW. Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis. Pediatric Pulmonology. 38: 204-9. PMID 15274098 DOI: 10.1002/Ppul.20054 |
0.365 |
|
2004 |
Ziady AG, Kim J, Colla J, Davis PB. Defining strategies to extend duration of gene expression from targeted compacted DNA vectors. Gene Therapy. 11: 1378-90. PMID 15269710 DOI: 10.1038/Sj.Gt.3302299 |
0.31 |
|
2004 |
Perez A, Davis PB. Gene profile changes after Pseudomonas aeruginosa exposure in immortalized airway epithelial cells. Journal of Structural and Functional Genomics. 5: 179-94. PMID 15263834 DOI: 10.1023/B:Jsfg.0000028982.59273.Bd |
0.355 |
|
2004 |
van Heeckeren AM, Schluchter MD, Drumm ML, Davis PB. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 287: L944-52. PMID 15246977 DOI: 10.1152/Ajplung.00387.2003 |
0.39 |
|
2004 |
van Heeckeren AM, Schluchter M, Xue L, Alvarez J, Freedman S, St George J, Davis PB. Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice. Infection and Immunity. 72: 1479-86. PMID 14977953 DOI: 10.1128/Iai.72.3.1479-1486.2004 |
0.337 |
|
2004 |
Van Heeckeren AM, Scaria A, Schluchter MD, Ferkol TW, Wadsworth S, Davis PB. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. American Journal of Physiology. Lung Cellular and Molecular Physiology. 286: L717-26. PMID 14514520 DOI: 10.1152/Ajplung.00227.2003 |
0.369 |
|
2004 |
Ziady AG, Wojtkicwicz G, Davis PB, Lee Z. 832. Radioscintigraphy of sec-R Directed CFTR Gene Transfer in CF Mice Following Intranasal Administration Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.733 |
0.323 |
|
2004 |
Ziady AG, Poleman J, Heeckeren Cv, Heeckeren Av, Davis PB. 829. Preferential Transfection of Tissue Macrophages Following Intravenous Administration of sec-R Targeted hCFTR DNA Enhances Survival of CF Mice Inoculated with Pseudomonas aeruginosa Agar Beads Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.730 |
0.369 |
|
2004 |
Ziady AG, Kim J, Colla J, Davis PB. 358. Route of Administration of sec-R Targeted Compacted DNA Influences Both the Site of Expression and Host Immune Response to the Vector Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.286 |
0.314 |
|
2003 |
Ziady AG, Gedeon CR, Miller T, Quan W, Payne JM, Hyatt SL, Fink TL, Muhammad O, Oette S, Kowalczyk T, Pasumarthy MK, Moen RC, Cooper MJ, Davis PB. Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 936-47. PMID 14664796 DOI: 10.1016/J.Ymthe.2003.07.007 |
0.347 |
|
2003 |
Chmiel JF, Davis PB. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respiratory Research. 4: 8. PMID 14511398 DOI: 10.1186/1465-9921-4-8 |
0.371 |
|
2003 |
Konstan MW, Krenicky JE, Finney MR, Kirchner HL, Hilliard KA, Hilliard JB, Davis PB, Hoppel CL. Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects. The Journal of Pharmacology and Experimental Therapeutics. 306: 1086-91. PMID 12807998 DOI: 10.1124/Jpet.103.052449 |
0.361 |
|
2003 |
Ziady AG, Davis PB, Konstan MW. Non-viral gene transfer therapy for cystic fibrosis. Expert Opinion On Biological Therapy. 3: 449-58. PMID 12783613 DOI: 10.1517/14712598.3.3.449 |
0.357 |
|
2003 |
Ferkol T, Cohn LA, Phillips TE, Smith A, Davis PB. Targeted delivery of antiprotease to the epithelial surface of human tracheal xenografts. American Journal of Respiratory and Critical Care Medicine. 167: 1374-9. PMID 12615618 DOI: 10.1164/Rccm.200209-1119Oc |
0.395 |
|
2003 |
Davis PB, Ziady AG. Non-viral methods of gene transfer to airway epithelium Gene Therapy and Regulation. 2: 77-90. DOI: 10.1163/156855803762295440 |
0.348 |
|
2002 |
Konstan MW, Davis PB. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis. Advanced Drug Delivery Reviews. 54: 1409-23. PMID 12458152 DOI: 10.1016/S0169-409X(02)00146-1 |
0.379 |
|
2002 |
Schluchter MD, Konstan MW, Davis PB. Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients. Statistics in Medicine. 21: 1271-87. PMID 12111878 DOI: 10.1002/Sim.1104 |
0.318 |
|
2002 |
Ziady AG, Kelley TJ, Milliken E, Ferkol T, Davis PB. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 413-9. PMID 11945068 DOI: 10.1006/Mthe.2002.0556 |
0.367 |
|
2002 |
Hilliard JB, Konstan MW, Davis PB. Inflammatory mediators in CF patients. Methods in Molecular Medicine. 70: 409-31. PMID 11917540 DOI: 10.1385/1-59259-187-6:409 |
0.325 |
|
2001 |
Gupta S, Eastman J, Silski C, Ferkol T, Davis PB. Single chain Fv: a ligand in receptor-mediated gene delivery. Gene Therapy. 8: 586-92. PMID 11320404 DOI: 10.1038/Sj.Gt.3301451 |
0.344 |
|
2001 |
Kube D, Sontich U, Fletcher D, Davis PB. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. American Journal of Physiology. Lung Cellular and Molecular Physiology. 280: L493-502. PMID 11159033 DOI: 10.1152/Ajplung.2001.280.3.L493 |
0.366 |
|
2001 |
Kube D, Adams L, Perez A, Davis PB. Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport. American Journal of Physiology. Lung Cellular and Molecular Physiology. 280: L482-92. PMID 11159032 DOI: 10.1152/Ajplung.2001.280.3.L482 |
0.382 |
|
2000 |
Davis PB, Kercsmar CM. Growth in children with chronic lung disease. The New England Journal of Medicine. 342: 887-8. PMID 10727595 DOI: 10.1056/Nejm200003233421210 |
0.34 |
|
2000 |
Ferkol T, Eckman E, Swaidani S, Silski C, Davis P. Transport of bifunctional proteins across respiratory epithelial cells via the polymeric immunoglobulin receptor. American Journal of Respiratory and Critical Care Medicine. 161: 944-51. PMID 10712347 DOI: 10.1164/Ajrccm.161.3.9907018 |
0.36 |
|
2000 |
Xie J, Zhao J, Davis PB, Ma J. Conformation, independent of charge, in the R domain affects cystic fibrosis transmembrane conductance regulator channel openings. Biophysical Journal. 78: 1293-305. PMID 10692317 DOI: 10.1016/S0006-3495(00)76685-9 |
0.304 |
|
2000 |
van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, Erokwu B, Haxhiu MA, Ferkol TW. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. American Journal of Respiratory and Critical Care Medicine. 161: 271-9. PMID 10619831 DOI: 10.1164/Ajrccm.161.1.9903019 |
0.338 |
|
1999 |
Eckman EA, Mallender WD, Szegletes T, Silski CL, Schreiber JR, Davis PB, Ferkol TW. In vitro transport of active alpha(1)-antitrypsin to the apical surface of epithelia by targeting the polymeric immunoglobulin receptor. American Journal of Respiratory Cell and Molecular Biology. 21: 246-52. PMID 10423408 DOI: 10.1165/Ajrcmb.21.2.3687 |
0.389 |
|
1999 |
Zerhusen B, Zhao J, Xie J, Davis PB, Ma J. A single conductance pore for chloride ions formed by two cystic fibrosis transmembrane conductance regulator molecules. The Journal of Biological Chemistry. 274: 7627-30. PMID 10075649 DOI: 10.1074/Jbc.274.12.7627 |
0.305 |
|
1998 |
Ma J, Davis PB. What we know and what we do not know about cystic fibrosis transmembrane conductance regulator. Clinics in Chest Medicine. 19: 459-71, v-vi. PMID 9759549 DOI: 10.1016/S0272-5231(05)70093-9 |
0.322 |
|
1998 |
Bryan R, Kube D, Perez A, Davis P, Prince A. Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. American Journal of Respiratory Cell and Molecular Biology. 19: 269-77. PMID 9698599 DOI: 10.1165/Ajrcmb.19.2.2889 |
0.375 |
|
1997 |
Davis PB. The decline and fall of pulmonary function in cystic fibrosis: new models, new lessons. The Journal of Pediatrics. 131: 789-90. PMID 9427876 DOI: 10.1016/S0022-3476(97)70019-2 |
0.317 |
|
1997 |
Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. The Journal of Clinical Investigation. 100: 2810-5. PMID 9389746 DOI: 10.1172/Jci119828 |
0.384 |
|
1997 |
Ziady AG, Perales JC, Ferkol T, Gerken T, Beegen H, Perlmutter DH, Davis PB. Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor. The American Journal of Physiology. 273: G545-52. PMID 9277436 DOI: 10.1152/Ajpgi.1997.273.2.G545 |
0.316 |
|
1997 |
Davis PB, Byard PJ, Konstan MW. Identifying treatments that halt progression of pulmonary disease in cystic fibrosis. Pediatric Research. 41: 161-5. PMID 9029632 DOI: 10.1203/00006450-199702000-00001 |
0.355 |
|
1996 |
Xie J, Drumm ML, Zhao J, Ma J, Davis PB. Human epithelial cystic fibrosis transmembrane conductance regulator without exon 5 maintains partial chloride channel function in intracellular membranes. Biophysical Journal. 71: 3148-56. PMID 8968585 DOI: 10.1016/S0006-3495(96)79508-5 |
0.354 |
|
1996 |
Perez A, Risma KA, Eckman EA, Davis PB. Overexpression of R domain eliminates cAMP-stimulated Cl- secretion in 9/HTEo- cells in culture. The American Journal of Physiology. 271: L85-92. PMID 8760136 DOI: 10.1152/Ajplung.1996.271.1.L85 |
0.325 |
|
1995 |
Chetty A, Davis P, Infeld M. Effect of elastase on the directional migration of lung fibroblasts within a three-dimensional collagen matrix. Experimental Lung Research. 21: 889-99. PMID 8591792 DOI: 10.3109/01902149509031769 |
0.334 |
|
1995 |
Ferkol T, Perales JC, Eckman E, Kaetzel CS, Hanson RW, Davis PB. Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. The Journal of Clinical Investigation. 95: 493-502. PMID 7860731 DOI: 10.1172/Jci117690 |
0.366 |
|
1995 |
Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. Journal of Clinical Epidemiology. 48: 1041-9. PMID 7775991 DOI: 10.1016/0895-4356(94)00230-N |
0.333 |
|
1995 |
Davis PB. Intruder in the dust: why are dust mites such effective allergens? American Journal of Respiratory Cell and Molecular Biology. 12: 367-8. PMID 7695915 DOI: 10.1165/Ajrcmb.12.4.7695915 |
0.329 |
|
1995 |
Sharma GD, Tosi MF, Stern RC, Davis PB. Progression of pulmonary disease after disappearance of Pseudomonas in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 152: 169-73. PMID 7599818 DOI: 10.1164/Ajrccm.152.1.7599818 |
0.371 |
|
1995 |
Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. The New England Journal of Medicine. 332: 848-54. PMID 7503838 DOI: 10.1056/Nejm199503303321303 |
0.363 |
|
1995 |
Xie J, Drumm ML, Ma J, Davis PB. Intracellular loop between transmembrane segments IV and V of cystic fibrosis transmembrane conductance regulator is involved in regulation of chloride channel conductance state. The Journal of Biological Chemistry. 270: 28084-91. PMID 7499295 DOI: 10.1074/Jbc.270.47.28084 |
0.356 |
|
1995 |
Eckman EA, Cotton CU, Kube DM, Davis PB. Dietary changes improve survival of CFTR S489X homozygous mutant mouse. The American Journal of Physiology. 269: L625-30. PMID 7491981 DOI: 10.1152/Ajplung.1995.269.5.L625 |
0.315 |
|
1994 |
Davis PB. Evolution of therapy for cystic fibrosis. The New England Journal of Medicine. 331: 672-3. PMID 8052279 DOI: 10.1056/Nejm199409083311011 |
0.328 |
|
1993 |
Infeld MD, Brennan JA, Davis PB. Human fetal lung fibroblasts promote invasion of extracellular matrix by normal human tracheobronchial epithelial cells in vitro: a model of early airway gland development. American Journal of Respiratory Cell and Molecular Biology. 8: 69-76. PMID 8417759 DOI: 10.1165/Ajrcmb/8.1.69 |
0.337 |
|
1993 |
Kercsmar CM, Davis PB. Resistance of human tracheal epithelial cells to killing by neutrophils, neutrophil elastase, and Pseudomonas elastase. American Journal of Respiratory Cell and Molecular Biology. 8: 56-62. PMID 8417757 DOI: 10.1165/Ajrcmb/8.1.56 |
0.351 |
|
1993 |
Ferkol T, Kaetzel CS, Davis PB. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. The Journal of Clinical Investigation. 92: 2394-400. PMID 8227356 DOI: 10.1172/Jci116845 |
0.356 |
|
1992 |
Infeld MD, Brennan JA, Davis PB. Human tracheobronchial epithelial cells direct migration of lung fibroblasts in three-dimensional collagen gels. The American Journal of Physiology. 262: L535-41. PMID 1590405 DOI: 10.1152/Ajplung.1992.262.5.L535 |
0.326 |
|
1992 |
Davis PB, Silski CL, Liedtke CM. Amiloride antagonizes beta-adrenergic stimulation of cAMP synthesis and Cl- secretion in human tracheal epithelial cells American Journal of Respiratory Cell and Molecular Biology. 6: 140-145. PMID 1347224 DOI: 10.1165/Ajrcmb/6.2.140 |
0.341 |
|
1991 |
Fiedler MA, Kaetzel CS, Davis PB. Sustained production of secretory component by human tracheal epithelial cells in primary culture. The American Journal of Physiology. 261: L255-61. PMID 1928359 DOI: 10.1152/Ajplung.1991.261.4.L255 |
0.316 |
|
1991 |
Davis PB. Cystic fibrosis from bench to bedside New England Journal of Medicine. 325: 575-577. PMID 1906988 DOI: 10.1056/Nejm199108223250809 |
0.364 |
|
1991 |
Chung Y, Kercsmar CM, Davis PB. Ferret tracheal epithelial cells grown in vitro are resistant to lethal injury by activated neutrophils. American Journal of Respiratory Cell and Molecular Biology. 5: 125-32. PMID 1892642 DOI: 10.1165/Ajrcmb/5.2.125 |
0.319 |
|
1991 |
Kercsmar CM, Chung Y, Davis PB. Receptor-mediated cAMP production in adult and infant ferret tracheal epithelium. Pediatric Research. 30: 75-82. PMID 1679920 DOI: 10.1203/00006450-199107000-00016 |
0.314 |
|
1990 |
Orkin Lewin L, Byard PJ, Davis PB. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients Journal of Clinical Epidemiology. 43: 125-131. PMID 2303842 DOI: 10.1016/0895-4356(90)90175-O |
0.335 |
|
1990 |
Kercsmar CM, Infeld MD, Silski CL, Davis PB. Adenosine 3:5' cyclic monophosphate synthesis by human tracheal epithelial cells. American Journal of Respiratory Cell and Molecular Biology. 2: 33-9. PMID 2155012 DOI: 10.1165/Ajrcmb/2.1.33 |
0.326 |
|
1990 |
Konstan MW, Vargo KM, Davis PB. Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis American Review of Respiratory Disease. 141: 186-192. PMID 2153353 DOI: 10.1164/Ajrccm/141.1.186 |
0.38 |
|
1990 |
Davis PB, Silski CL, Kercsmar CM, Infeld M. Beta-adrenergic receptors on human tracheal epithelial cells in primary culture. The American Journal of Physiology. 258: C71-6. PMID 1689114 DOI: 10.1152/Ajpcell.1990.258.1.C71 |
0.316 |
|
1988 |
Davis PB, Vargo K. Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis. Thorax. 42: 120-5. PMID 3433235 DOI: 10.1136/Thx.42.2.120 |
0.334 |
|
1988 |
Byard PJ, Davis PB. Pulmonary function in obligate heterozygotes for cystic fibrosis. The American Review of Respiratory Disease. 138: 312-316. PMID 3195830 DOI: 10.1164/Ajrccm/138.2.312 |
0.31 |
|
1987 |
Davis PB. Lymphocyte and granulocyte phosphatidylethanolamine N-methyltransferase: properties and activity in cystic fibrosis. Pediatric Research. 20: 1290-6. PMID 3025802 DOI: 10.1203/00006450-198612000-00021 |
0.324 |
|
1984 |
Davis PB, Dieckman L, Boat TF, Stern RC, Doershuk CF. The alpha 2-adrenergic system of the platelet in cystic fibrosis. The American Journal of the Medical Sciences. 288: 104-8. PMID 6091455 DOI: 10.1097/00000441-198410000-00002 |
0.339 |
|
1983 |
Davis PB, Dieckman L, Boat TF, Stern RC, Doershuk CF. Beta adrenergic receptors in lymphocytes and granulocytes from patients with cystic fibrosis. The Journal of Clinical Investigation. 71: 1787-95. PMID 6306054 DOI: 10.1172/Jci110934 |
0.352 |
|
1983 |
Davis PB, Kaliner M. Autonomic nervous system abnormalities in cystic fibrosis. Journal of Chronic Diseases. 36: 269-78. PMID 6298269 DOI: 10.1016/0021-9681(83)90062-0 |
0.344 |
|
1978 |
Davis PB, Braunstein M, Jay C. Decreased adenosine 3′:5′-monophosphate response to isoproterenol in cystic fibrosis leukocytes Pediatric Research. 12: 703-707. PMID 209391 DOI: 10.1203/00006450-197806000-00005 |
0.341 |
|
Show low-probability matches. |